Journal of Labelled Compounds and Radiopharmaceuticals · 1990 · 13 citations · 9 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryOrganometallic ChemistrySynthetic Medicinal ChemistryChemoenzymatic SynthesisNatural Product Drug DiscoveryChemical Synthesis Of AnaloguesMedicinal Chemistry Applications
Abstract (S)‐2‐Hydroxy‐6‐methoxy‐N‐[(1‐ethyl‐2‐pyrrolidinyl)methyl]benzamide ((S)‐BZM; (S)‐ 5a ), the precursor of (S)‐2‐hydroxy‐3‐ 123 I‐iodo‐6‐methoxy‐N‐[(1‐ethyl‐2‐pyrrolidinyl)methyl]benzamide ((S)‐ 123 I‐IBZM) was synthesized via a simple method and in high yield starting from 2,6‐dimethoxybenzoic acid ( 1a ). N‐Hydroxysuccinimide/dicyclohexyl‐carbodiimide (DCC) was used as activating system in the reaction of 1a with (S)‐2‐aminomethyl‐1‐ethylpyrrolidine ( 3a ).
9
In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
Hank F. Kung, Sangren Pan, Mei‐Ping Kung et al. · PubMed · 1989 · 164 citations
Medicine, Neuroscience, Pharmacology +15
Hank F. Kung, Ravindra Kasliwal, Sangren Pan et al. · Journal of Medicinal Chemistry · 1988 · 84 citations · Full text
Tomas de Paulis, Yatendra Kumar, Lars Johansson et al. · Journal of Medicinal Chemistry · 1986 · 72 citations · Full text